A Crossover Adherence and Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention
Status:
Not yet recruiting
Trial end date:
2023-01-15
Target enrollment:
Participant gender:
Summary
A randomized, crossover study to compare adherence, preference and acceptability of an
over-encapsulated dual prevention pill (DPP capsule) containing oral pre-exposure prophylaxis
(PrEP) and a combined oral contraceptive (COC) versus two separate tablets (PrEP and COC)
among women at risk of HIV and unintended pregnancy in Johannesburg, South Africa